Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Boileau, Jean-François; Poirier, Brigitte; Basik, Mark; Holloway, Claire; Gaboury, Louis; Sidéris, Lucas; Meterissian, Sarkis; Arnaout, Angel; Brackstone, Muriel; R. McCready, David; E. Karp, Stephen; Trop, Isabelle; Lisbona, A.; C. Wright, Frances; Younan, Rami; Provencher, Louise; Patocskai, Érica; Ömeroğlu, Atilla; Robidoux, André

doi:10.1200/jco.2014.55.7827

Public

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Published in Journal of Clinical Oncology • Dec 2, 2014

Authors:

Jean-François Boileau

Brigitte Poirier

Mark Basik

Abstract

PURPOSE: An increasing proportion of patients (> 30%) with node-positive breast cancer will obtain an axillary pathologic complete response after neoadjuvant chemotherapy (NAC). If sentinel node (SN) biopsy (SNB) is accurate in this setting, completion node dissection (CND) morbidity could be avoide...

Subject

Medicine

Sentinel node

Breast cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!